
May 7 (Reuters) - Valneva SE VLS.PA:
VALNEVA PROVIDES UPDATE FOLLOWING EUROPEAN MEDICINES AGENCY ANNOUNCEMENT ON USE OF IXCHIQ® IN ELDERLY
VALNEVA SE: TO CONTINUE TO MONITOR ALL REPORTED SERIOUS ADVERSE EVENTS AND FULLY COOPERATE WITH HEALTH AUTHORITIES
VALNEVA SE: CONTINUES TO SEE A POSITIVE RISK-BENEFIT IN VAST MAJORITY OF PEOPLE WITH POTENTIAL EXPOSURE TO DISEASE